News

Cabaletta Bio, Inc. ("Cabaletta” or the "Company”) (Nasdaq: CABA), a clinical-stage biotechnology company focused on developing and launching the first curative targeted cell therapies designed ...
Cabaletta Bio, Inc. ("Cabaletta” or the "Company”) (Nasdaq: CABA), a clinical-stage biotechnology company focused on developing and launching the first curative targeted cell therapies designed ...